Skip to main content
. Author manuscript; available in PMC: 2005 Oct 5.
Published in final edited form as: Gene Ther. 2005 Sep;12(18):1377–1384. doi: 10.1038/sj.gt.3302533

Figure 8.

Figure 8

SP immunoreactivity was reduced in diabetic animals compared to control (right); diabetic animals inoculated with T0VEGF showed substantial preservation of SP-IR (P<0.0001) compared to diabetic or diabetic inoculated with Q0ZHG. Mean±s.e.m.; * P<0.0001 compared to diabetic or diabetic inoculated with Q0ZHG; n = 5 animals per group.